Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$11.4 - $14.6 $45,600 - $58,400
4,000 New
4,000 $52,000
Q2 2021

Aug 16, 2021

SELL
$18.57 - $35.68 $18,570 - $35,680
-1,000 Closed
0 $0
Q1 2021

May 20, 2021

SELL
$31.0 - $55.72 $5.37 Million - $9.66 Million
-173,300 Reduced 99.43%
1,000 $35,000
Q1 2021

May 13, 2021

BUY
$31.0 - $55.72 $5.4 Million - $9.71 Million
174,300 New
174,300 $6.05 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $54.4M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Axiom Investment Management LLC Portfolio

Follow Axiom Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axiom Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axiom Investment Management LLC with notifications on news.